Schedule 13G ownership disclosure

Aclaris Therapeutics Inc

Common Stock, $0.00001 par value · CUSIP: 00461U105

Event date: 2025-12-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Biosion, Inc.

    Shares: 11,281,950 · Class: 9.4%

  • Bonita Biotech (HK) Ltd

    Shares: 11,281,950 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-26-000098
Form type
SCHEDULE 13G/A
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Jan 09, 2026
Reporting period
Dec 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub